Literature DB >> 20468889

Heparin in clinical medicine.

D L Levene.   

Abstract

Heparin is a commonly-used drug administered intravenously as an anticoagulant. This article describes the pharmacological effect of the drug, indications for its use, methods of administration, and dosage.

Entities:  

Year:  1973        PMID： 20468889      PMCID： PMC2370828     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  11 in total

1.  Low doses of heparin in prevention of deep-vein thrombosis.

Authors:  V V Kakkar; E S Field; A N Nicolaides; P T Flute
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

2.  Small doses of heparin in the prevention of deep venous thrombosis.

Authors:  J M Ham; J Lawrence
Journal:  Lancet       Date:  1971-08-21       Impact factor: 79.321

3.  Heparin for septic abortion and the prevention of endotoxic shock.

Authors:  R R Margulis; R W Dustin; J R Lovell; H Robb; C Jabs
Journal:  Obstet Gynecol       Date:  1971-03       Impact factor: 7.661

4.  Successful treatment of post-partum renal failure with heparin.

Authors:  I Timor-Tritsch; O S Better; I Tatarsky; C Chaimowitz; A Peretz; H Abramovici
Journal:  Br Med J       Date:  1970-10-24

5.  Meningococcemia and consumption coagulopathy treated with heparin and dextran 70.

Authors:  L Ellman
Journal:  Arch Intern Med       Date:  1971-01

6.  The activated partial thromboplastin time in the control of heparin treatment.

Authors:  J Hirsh; E F O'Sullivan; A S Gallus; M Martin
Journal:  Australas Ann Med       Date:  1970-11

7.  Partial thromboplastin time in heparin therapy.

Authors:  C O Burdick; C W Colman
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  Use of heparin for the therapeutic-prophylactic treatment of decompression sickness.

Authors:  E Reeves; R D Workman
Journal:  Aerosp Med       Date:  1971-01

9.  Monitoring heparin therapy with the activated partial thromboplastin time.

Authors:  R K Stuart; A Michel
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

10.  Heparin efficacy in burns. II. Human thermal burn treatment with large doses of topical and parenteral heparin.

Authors:  M J Saliba
Journal:  Aerosp Med       Date:  1970-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.